RBC Capital reiterates IBM stock Outperform rating on AI security

IBM is starting to look less like a cyclical legacy software rerating and more like a policy-backed infrastructure beneficiary with multiple embedded call options. The combination of federal cyber/defense work and quantum funding creates a more durable narrative than the market usually assigns to a mature large-cap tech name, because these revenue streams are sticky, procurement-driven, and less exposed to enterprise IT budget pauses. The second-order effect is that IBM can fund higher R&D intensity without the market penalizing near-term margin compression as long as the AI/security story keeps winning analyst revisions.

The more interesting angle is that the upside may be coming from perception lag rather than fundamental surprise. If the market starts treating IBM as a “strategic compute and security platform” instead of a slow-growth software company, multiple expansion could do more work than earnings growth over the next 6-12 months. That said, quantum-related capital allocation is a long-dated promise: the stock can rerate on policy headlines, but the actual cash flow inflection from quantum is likely years away, so any premium may be vulnerable if execution slips or the AI security initiative fails to show monetization.

Consensus seems to be underappreciating the asymmetry between near-term contracted revenue and long-term optionality. The bull case does not require IBM to win a broad AI platform war; it only needs to remain an enterprise trust layer while the market pays up for defensible infrastructure exposure. The risk is that investors overstate quantum as a near-term earnings lever and underweight the possibility that the stock becomes range-bound again once the headline cycle fades.